Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
5,806 results in PubMed
Peer-reviewed biomedical literature from the US National Library of Medicine, most relevant first. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Treatment outcomes for newly diagnosed, treatment-naïve TP53-mutated acute myeloid leukemia: a systematic review and meta-analysis.
Daver NG, Iqbal S, Renard C, et al. · J Hematol Oncol · 2023Meta-Analysis, Systematic Review
- Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial.
Lambert J, Pautas C, Terré C, et al. · Haematologica · 2019Clinical Trial, Phase III, Multicenter Study
- Indirect treatment comparison of ivosidenib and other therapies in patients with newly diagnosed acute myeloid leukemia.
Gil-Sierra MD, Mantopoulos T, Barouma I, et al. · Future Oncol · 2025Systematic Review, Comparative Study
- Acute myeloid leukemia during pregnancy: a systematic review and meta-analysis.
Horowitz NA, Henig I, Henig O, et al. · Leuk Lymphoma · 2018Meta-Analysis, Systematic Review
- Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML.
Risueño A, See WL, Bluemmert I, et al. · Leuk Res · 2024Clinical Trial, Phase III, Randomized Controlled Trial
- Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial.
Xuan L, Wang Y, Huang F, et al. · Lancet Oncol · 2020Clinical Trial, Phase III, Multicenter Study
- Oral decitabine-cedazuridine in acute myeloid leukaemia.
Bouligny IM, DiNardo CD · Br J Haematol · 2024Randomized Controlled Trial
- Systematic review and meta-analysis evaluating clinical outcomes in adult acute myeloid leukemia patients with central nervous system involvement.
Goulart H, Sastow D, Moshier E, et al. · Leuk Res · 2024Meta-Analysis, Systematic Review
- Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo-Controlled Phase 2 DELTA Trial.
Sockel K, Röllig C, Mütherig A, et al. · Am J Hematol · 2025Randomized Controlled Trial, Clinical Trial, Phase II
- Gilteritinib Plus Azacitidine Combination Shows Promise in Newly Diagnosed FLT3-Mutated AML.
Oncologist · 2021Randomized Controlled Trial
- Acute myeloid leukemia treatment outcomes with isocitrate dehydrogenase mutations: A systematic review and meta-analysis.
Qin H, Xu R, Yang Y · Medicine (Baltimore) · 2024Systematic Review, Meta-Analysis
- Clinical relevance of long non-coding RNA in acute myeloid leukemia: A systematic review with meta-analysis.
Priya, Garg M, Talwar R, et al. · Leuk Res · 2024Systematic Review, Meta-Analysis
- Efficacy of epigenetic agents for older patients with acute myeloid leukemia and myelodysplastic syndrome in randomized controlled trials: a systematic review and network meta-analysis.
Oh S, Kim E · Clin Exp Med · 2023Systematic Review, Network Meta-Analysis
- Investigational venetoclax combination therapy in acute myeloid leukemia - a systematic review and meta-analysis.
Shimony S, Rozental A, Bewersdorf JP, et al. · Haematologica · 2022Meta-Analysis, Systematic Review
- Efficacy and safety of venetoclax plus azacitidine based regimens in the treatment of relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis.
Cai Q, Xiao J, Weng C, et al. · Ann Hematol · 2025Systematic Review, Meta-Analysis
- Acute myeloid leukemia in the elderly: what constitutes treatment value?
Nabhan C, Kamat S, Karl Kish J · Leuk Lymphoma · 2019Meta-Analysis
- Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study.
Geissler K, Koristek Z, Del Castillo TB, et al. · Br J Haematol · 2024Randomized Controlled Trial, Multicenter Study
- Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemia.
Aldoss I, Zhang J, Pillai R, et al. · Br J Haematol · 2019Clinical Trial, Letter
- Acute promyelocytic leukemia during pregnancy: a systematic analysis of outcome.
Verma V, Giri S, Manandhar S, et al. · Leuk Lymphoma · 2016Meta-Analysis, Research Support, Non-U.S. Gov't
- Treatment Outcomes of Intracranial Myeloid Sarcomas: A Meta-Analysis.
Lee D, Omofoye OA, Nuño MA, et al. · World Neurosurg · 2021Meta-Analysis, Systematic Review
- Myeloid growth factors in acute myeloid leukemia: systematic review of randomized controlled trials.
Heuser M, Zapf A, Morgan M, et al. · Ann Hematol · 2011Meta-Analysis, Research Support, Non-U.S. Gov't
- Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia-A systematic review and meta-analysis.
Bewersdorf JP, Giri S, Tallman MS, et al. · Transfusion · 2020Meta-Analysis, Research Support, N.I.H., Extramural
- Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis.
Shahzad M, Nguyen A, Hussain A, et al. · Front Immunol · 2023Meta-Analysis, Systematic Review
- Prognostic significance of KMT2A-PTD in patients with acute myeloid leukaemia: a systematic review and meta-analysis.
Ye W, Ma M, Wu X, et al. · BMJ Open · 2023Meta-Analysis, Systematic Review
- The role of interim bone marrow assessments in acute myeloid leukemia - A systematic review and meta-analysis.
Lei Y, Tang Z, Reese JA, et al. · Leuk Res · 2025Systematic Review, Meta-Analysis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.